Remove Drug Development Remove Examples Remove Health Data Remove Health Information
article thumbnail

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

Exec Summary: Self-sovereign identity (SSI) holds immense potential to revolutionize the future of health data, empowering individuals to take control of their information and fostering a more secure, transparent, and patient-centric healthcare ecosystem.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

Virtual care also generates a wealth of patient data captured in real-time reporting across patient populations, health information, treatment responses, lifestyle patterns and medication adherence. Digital health companies can help identify new drug targets, design clinical trials and analyse data more effectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Blockchain ledger will let US residents sell personal Healthcare data

Lloyd Price

Most people don't know it but there is a multi-billion dollar industry that collects healthcare information, strips it of basic personal identifiers such as name, address and Social Security Number, and then sells it off to researchers, drug developers, marketers and others. "It's not fair. . "Despite

article thumbnail

Asaya and medical cannabis care in the era of personalised medicine

Lloyd Price

The COVID-19 pandemic has prompted widespread use of real-world data (1). Desperate for medical insights without delay, researchers, pharmaceutical companies and government agencies turned to health information captured through real-world data sources. Medical cannabis is a unique example in medicine where: 1.

article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

The treatment algorithms are personalized for each patient based on machine learning and ensure the right drug dosages and treatments for the right patient at the right time. For example, the Brigham Home Hospital program leveraged Biofourmis’ AI-based technology to improve outcomes while lowering costs by 38%, the company reported.